Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

COMy 2022 | Looking forward to ISA 2022

Joan Bladé • 12 May 2022
COMy 2022
Amyloidosis Multiple Myeloma Rare Diseases

In this video, Joan Bladé, MD, PhD, University of Barcelona, Barcelona, Spain, discusses the upcoming meeting of the International Society of Amyloidosis (ISA) being held in Heidelberg on September 4-8, 2022. Prof Bladé briefly discusses previous ISA meetings and further emphasizes the importance of these meetings as an educational platform for amyloidosis. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.

Disclosures

Honoraria for lectures: Janssen, BMS, Amgen, Takeda, Oncopeptides

More from Joan Bladé

1:02
How the amyloidosis treatment landscape has transformed in recent years
Joan Bladé • 12 May 2022
3:26
Managing and treating renal impairment in multiple myeloma
Joan Bladé • 12 May 2022
3:05
Amyloidosis classification and epidemiology
Joan Bladé • 4 Sep 2020
10:09
ISA 2020: continuing the amyloidosis conversation
Joan Bladé • 2 Sep 2020

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals